You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
One of PSI AIMS SIGs objectives is to support and contribute to working groups researching and developing tools that will help us use R in Pharmaceutical research. These wide ranging working groups focus on replication across software, development of packages and tools, application of statistical methods in R and R submissions. This article introduces you to some of the most popular working groups, whose collective remit is to encourage and support the use of R in regulatory research. PSI AIMS SIG actively supports these projects so check out what each does below and become active by joining PSI AIMS SIG or one or more of the projects!
**pharmaverse is a connected network of companies and individuals working to promote collaborative development of curated open source R packages for clinical reporting usage in pharma, in a space where previously we would only ever have worked in silos on our own closed source and often duplicative solutions**
76
75
@@ -132,7 +131,7 @@ See [openstatsware](https://www.openstatsware.org/) for more information.
**R Validation Hub is a cross-industry initiative whose mission is to enable the use of R by the Bio-Pharmaceutical Industry in a regulatory setting, where the output may be used in submissions to regulatory agencies.**
138
137
@@ -146,6 +145,8 @@ One of the earliest working groups initially set up by the PSI AIMS SIG in 2018
146
145
147
146
The R validation hub is still identifying and addressing issues and challenges with R implementation, and offers a range of free webinars throughout the year encouraging discussion and collaboration on a range of topics. See [R Validation Hub](https://www.pharmar.org/) for more information.
0 commit comments